• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非洲人群对新型冠状病毒(SARS-CoV-2)的抵抗力:一个值得探索的原因。

Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.

作者信息

Krishan Kewal, Kanchan Tanuj

机构信息

Department of Anthropology, Panjab University, Chandigarh, India,.

Department of Forensic Medicine and Toxicology, All India Institute of Medical Sciences Jodhpur, India.

出版信息

Acta Biomed. 2020 Sep 7;91(3):e2020023. doi: 10.23750/abm.v91i3.9872.

DOI:10.23750/abm.v91i3.9872
PMID:32921745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7717003/
Abstract

The pandemic caused by Novel Coronavirus SARS-CoV-2 shows its devastating effects all over the world. The American and the European countries are the worst-hit by this COVID-19 pandemic. However, most of the African countries excepting a few are less affected by this virus as far as the number of cases and deaths are concerned. The correspondence proposes that just like the abnormal haemoglobins HbS and HbC are found to provide immunity to the African populations against infectious diseases such as Plasmodium falciparum malaria The possibility of these abnormal haemoglobins offering certain protection against the Novel Coronavirus infection in these populations needs to be explored.

摘要

新型冠状病毒SARS-CoV-2引发的大流行在全球范围内显示出其毁灭性影响。美国和欧洲国家受此次COVID-19大流行的影响最为严重。然而,就病例数和死亡人数而言,除少数国家外,大多数非洲国家受这种病毒的影响较小。本信函提出,正如异常血红蛋白HbS和HbC被发现能使非洲人群对恶性疟原虫疟疾等传染病产生免疫力一样,需要探索这些异常血红蛋白在这些人群中对新型冠状病毒感染提供一定保护的可能性。

相似文献

1
Novel Coronavirus (SARS-CoV-2) resistance in African populations: A cause worth exploring.非洲人群对新型冠状病毒(SARS-CoV-2)的抵抗力:一个值得探索的原因。
Acta Biomed. 2020 Sep 7;91(3):e2020023. doi: 10.23750/abm.v91i3.9872.
2
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Mar 11;16(685):510-511.
3
Molecular Investigation of SARS-CoV-2 Proteins and Their Interactions with Antiviral Drugs.SARS-CoV-2 蛋白的分子研究及其与抗病毒药物的相互作用。
Viruses. 2020 Apr 14;12(4):445. doi: 10.3390/v12040445.
4
HIV and SARS-CoV-2: points to consider to face this new pandemic.人类免疫缺陷病毒与严重急性呼吸综合征冠状病毒2:应对这一新疫情需考虑的要点。
Medwave. 2020 Oct 27;20(9):e8049. doi: 10.5867/medwave.2020.09.8049.
5
Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.使用多梳蛋白抑制剂作为抗病毒药物靶向严重急性呼吸综合征冠状病毒2(SARS-CoV-2)
Epigenomics. 2020 May;12(10):811-812. doi: 10.2217/epi-2020-0154. Epub 2020 Jun 4.
6
Singapore COVID-19 Pandemic Response as a Successful Model Framework for Low-Resource Health Care Settings in Africa?新加坡的 COVID-19 疫情应对能否成为非洲资源匮乏的医疗保健环境的成功模式框架?
OMICS. 2020 Aug;24(8):470-478. doi: 10.1089/omi.2020.0077. Epub 2020 Jun 16.
7
Lithium for the 2019 novel coronavirus.锂用于治疗2019新型冠状病毒。 (不过从专业角度看,该表述不太符合医学常理,可能存在信息偏差,仅按要求翻译)
Med Hypotheses. 2020 Sep;142:109822. doi: 10.1016/j.mehy.2020.109822. Epub 2020 May 7.
8
Type 1 interferons as a potential treatment against COVID-19.1 型干扰素作为一种对抗 COVID-19 的潜在治疗方法。
Antiviral Res. 2020 Jun;178:104791. doi: 10.1016/j.antiviral.2020.104791. Epub 2020 Apr 7.
9
Effects of Gene-Eden-VIR and Novirin on SARS-CoV: Implications for COVID-19.基因伊甸-VIR和诺维林对严重急性呼吸综合征冠状病毒的作用:对2019冠状病毒病的启示。
J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20932523. doi: 10.1177/2515690X20932523.
10
[SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].[严重急性呼吸综合征冠状病毒2蛋白酶:开发抗2019冠状病毒病药物的理想靶点]
Med Sci (Paris). 2020 Jun-Jul;36(6-7):555-558. doi: 10.1051/medsci/2020106. Epub 2020 Jun 19.

引用本文的文献

1
The regarding the call to explore the unexpected low severity of COVID-19 in Sub-Saharan Africa.关于探讨撒哈拉以南非洲地区新冠病毒疾病(COVID-19)意外低严重程度的呼吁。
Acta Biomed. 2020 Nov 10;91(4):e2020151. doi: 10.23750/abm.v91i4.10718.

本文引用的文献

1
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).羟氯喹治疗严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)的体外抗病毒活性和优化剂量设计预测。
Clin Infect Dis. 2020 Jul 28;71(15):732-739. doi: 10.1093/cid/ciaa237.
2
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19.氯喹和羟氯喹作为对抗新型冠状病毒肺炎的现有武器。
Int J Antimicrob Agents. 2020 Apr;55(4):105932. doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4.
3
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.瑞德西韦和氯喹在体外能有效抑制新出现的新型冠状病毒(2019 - 新冠病毒)。
Cell Res. 2020 Mar;30(3):269-271. doi: 10.1038/s41422-020-0282-0. Epub 2020 Feb 4.
4
Malaria continues to select for sickle cell trait in Central Africa.在中非,疟疾持续促使镰状细胞性状的出现。
Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):7051-4. doi: 10.1073/pnas.1505665112. Epub 2015 May 4.
5
Sickle cell anaemia and malaria.镰状细胞贫血与疟疾。
Mediterr J Hematol Infect Dis. 2012;4(1):e2012065. doi: 10.4084/MJHID.2012.065. Epub 2012 Oct 3.
6
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria.奎宁,现代社会中的古老抗疟药物:在疟疾治疗中的作用。
Malar J. 2011 May 24;10:144. doi: 10.1186/1475-2875-10-144.
7
Abnormal display of PfEMP-1 on erythrocytes carrying haemoglobin C may protect against malaria.携带血红蛋白C的红细胞上PfEMP-1的异常表达可能预防疟疾。
Nature. 2005 Jun 23;435(7045):1117-21. doi: 10.1038/nature03631.
8
Protection afforded by sickle-cell trait against subtertian malareal infection.镰状细胞性状对间日疟感染的保护作用。
Br Med J. 1954 Feb 6;1(4857):290-4. doi: 10.1136/bmj.1.4857.290.